Immunofluorescence detection of liver cell membrane autoantibodies using PLC/PRF/5 cells
- 1 April 1985
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 15 (2), 64-68
- https://doi.org/10.1111/j.1365-2362.1985.tb00146.x
Abstract
Detection of liver cell membrane autoantibodies is routinely performed by immunofluorescence testing of patient sera on rabbit hepatocyte suspensions. We have investigated the possible use of cells from the PLC/PRF/5 human hepatoma cell-line. These cells were employed as substrate in an immunofluorescence test which was compared with the conventional rabbit hepatocyte assay. We found a close correlation between the results obtained with these different substrates on visual reading. We furthermore compared visual reading of immunofluorescence preparations with flow-cytometrical analysis of immunostained cell suspensions. The results with these different methods were largely confirmatory. The PLC/PRF/5 cells are easily available and should therefore be regarded as a highly valuable new substrate for detection of liver cell membrane autoantibodies. Flow cytometry appears to be a technically simple and reliable method for quantitative analysiKeywords
This publication has 6 references indexed in Scilit:
- Hepatitis B virus and host cell membrane antigens on a primary hepatocellular carcinoma cell lineLiver International, 1984
- Hepatocyte Membrane–Bound Igg and Circulating Liver–Specific Autoantibodies in Chronic Liver Disease: Relation to Hepatitis B Virus Serum Markers and Liver HistologyHepatology, 1983
- Clinical Evaluation of the Liver Cell Membrane Autoantibody AssayDigestion, 1982
- Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.The Journal of Immunology, 1981
- Liver-cell-membrane autoantibody specific for inflammatory liver diseases.BMJ, 1977
- Detection of a Liver-Membrane Autoantibody in HBsAg-negative Chronic Active HepatitisNew England Journal of Medicine, 1976